Stock listing

NASDAQ:NBRV Nabriva Therapeutics AG Stock

Follow Nabriva Therapeutics AG into a list and get an email when it puts out news.

Delisted NASDAQ:NBRV no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:NBRV
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Nabriva Therapeutics AG on 6ix

Calls
7 calls with a replay · 7 with a transcript · latest Nov 10, 2022
Decks
11 decks · latest Apr 15, 2021

Events

CallWhenStatus
Nabriva Therapeutics (NBRV) Q3 2022 Earnings CallThu, Nov 10, 2022 · 3:30 AM ETReplay
Nabriva Therapeutics (NBRV) Q2 2022 Earnings CallWed, Aug 03, 2022 · 4:30 PM ETReplay
Nabriva Therapeutics (NBRV) Q4 2021 Earnings CallTue, Mar 29, 2022 · 4:30 PM ETReplay
Nabriva Therapeutics (NBRV) Q3 2021 Earnings CallTue, Nov 09, 2021 · 4:30 PM ETReplay
Nabriva Therapeutics (NBRV) Q2 2021 Earnings CallThu, Aug 05, 2021 · 4:30 PM ETReplay
Nabriva Therapeutics (NBRV) Q1 2021 Earnings CallMon, Apr 05, 2021 · 4:30 PM ETReplay
Nabriva Therapeutics (NBRV) Q4 2020 Earnings CallThu, Mar 11, 2021 · 4:30 PM ETReplay

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (April 2021)Investor deck30 slidesApr 15, 2021
Q3 2019 Earnings PresentationEarnings27 slidesNov 12, 2019
Technical Presentation (May 2018)Technical36 slidesMay 21, 2018
Investor Presentation (November 2017)Investor deck57 slidesNov 7, 2017
Conference Presentation (September 2017)Conference28 slidesSep 18, 2017
Investor Day (June 2017)Investor day49 slidesJun 19, 2017
Investor Presentation (April 2017)Investor deck35 slidesApr 5, 2017
Investor Presentation (February 2017)Investor deck34 slidesFeb 15, 2017
Investor Presentation (January 2017)Investor deck29 slidesJan 9, 2017
Investor Presentation (April 2016)Investor deck31 slidesApr 12, 2016
All 11 decks
DeckKindSlidesDate
Investor Presentation (November 2015)Investor deck17 slidesNov 10, 2015

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Samuel D Isaly
Other companies: Synlogic Inc (Director · Aug 28, 2017 – Aug 28, 2017 · Past); Alpine Immune Sciences Inc (Director · Jul 24, 2017 – Jul 24, 2017 · Past); Whitehawk Therapeutics, Inc. (Director · Mar 15, 2017 – Mar 15, 2017 · Past); Roka Bioscience Inc (Director · Sep 21, 2016 – Sep 21, 2016 · Past); Loxo Oncology Inc (Director · Aug 10, 2016 – Dec 8, 2017 · Past); Audentes Therapeutics Inc (Director · Jul 19, 2016 – Jul 19, 2016 · Past); Cartesian Therapeutics, Inc. (Director · Jun 21, 2016 – Jun 27, 2016 · Past); Corvus Pharmaceuticals, Inc. (Director · May 18, 2016 – Jun 23, 2016 · Past); Intellia Therapeutics, Inc. (Director · May 11, 2016 – May 11, 2016 · Past); Adaptimmune Therapeutics PLC (Director · Jan 1, 2016 – Mar 27, 2017 · Past); Otonomy Inc (Director · Nov 17, 2015 – Nov 25, 2015 · Past); Dimension Therapeutics (Director · Oct 27, 2015 – Oct 27, 2015 · Past); Sierra Oncology Inc (Director · Jul 15, 2015 – Jul 21, 2015 · Past); Palvella Therapeutics, Inc. (Director · Jun 29, 2015 – Jul 6, 2015 · Past); Glaukos Corporation (Director · Jun 24, 2015 – Aug 31, 2017 · Past); Intercept Pharmaceuticals Inc (Director · Apr 9, 2013 – Jul 17, 2015 · Past); Supernus Pharmaceuticals, Inc. (Director · May 4, 2012 – May 4, 2012 · Past); Anthera Pharmaceuticals Inc (Director · May 9, 2011 – Jan 30, 2013 · Past); Amarin Corporation plc (Director · Jan 1, 2011 – Sep 4, 2012 · Past); NxStage Medical Inc (Director · Jul 23, 2008 – Dec 9, 2010 · Past); Albireo Pharma Inc (Director · Feb 12, 2008 – Jun 9, 2009 · Past); Aryx Therapeutics Inc (Director · Nov 7, 2007 – Nov 13, 2007 · Past); Insulet Corporation (Director · May 14, 2007 – May 14, 2007 · Past); Volcano Corp (Director · Jun 14, 2006 – Jun 20, 2006 · Past); Given Imaging Ltd (Director · May 24, 2006 – May 24, 2006 · Past); Avanir Pharmaceuticals Inc (Director · Feb 13, 2006 – May 31, 2006 · Past)
Director · Dec 30, 2016 – Dec 30, 2016 · Past
Charles A Rowland Jr
Other companies: Generation Bio Co (Director · Since at least Jun 11, 2020); Viking Therapeutics, Inc. (Director · Since at least Jul 1, 2017); Orchard Therapeutics PLC (Director · Jan 1, 2020 – Jan 24, 2024 · Past); Blueprint Medicines Corp (Director · Apr 30, 2015 – Jun 2, 2021 · Past); Vitae Pharmaceuticals Inc (Director · Sep 24, 2014 – Oct 25, 2016 · Past); BIND Therapeutics Inc (Director · May 28, 2014 – Jun 21, 2016 · Past); Idenix Pharmaceuticals Inc (Director · Jun 6, 2013 – Aug 5, 2014 · Past); Viropharma Inc (VP, Chief Financial Officer · Oct 20, 2008 – Jan 24, 2014 · Past)
Director · Dec 30, 2016 – Aug 3, 2022 · Past
Mark Corrigan
Other companies: Wave Life Sciences Ltd. (Director · Since at least Sep 4, 2019); Trevena, Inc. (Director · Jul 18, 2023 – Jun 13, 2024 · Past); Novelion Therapeutics Inc (Director · Mar 30, 2017 – Aug 9, 2018 · Past); CoLucid Pharmaceuticals Inc (Director · Oct 27, 2015 – Mar 1, 2017 · Past); Avanir Pharmaceuticals Inc (Director · Mar 18, 2014 – Mar 18, 2014 · Past); EPIRUS Biopharmaceuticals Inc (Director · Dec 21, 2009 – Jun 5, 2015 · Past); Cubist Pharmaceuticals Inc (Director · Jun 20, 2008 – Jan 21, 2015 · Past); Sepracor Inc (Executive VP, R&D · Mar 16, 2006 – Oct 20, 2009 · Past)
Director · Dec 30, 2016 – Aug 2, 2022 · Past
Stephen Webster
Other companies: Cullinan Therapeutics, Inc. (Chair of the Audit Committee · Since at least Jan 7, 2021); NextCure, Inc. (Director · Since at least May 8, 2019); Gritstone bio, Inc. (Director · Apr 26, 2024 – Apr 4, 2025 · Past); Tcr2 Therapeutics Inc (Director · Apr 30, 2020 – Jun 1, 2023 · Past); Viking Therapeutics, Inc. (Director · Apr 28, 2015 – Jan 2, 2020 · Past); Spark Therapeutics Inc (CHIEF FINANCIAL OFFICER · Jan 29, 2015 – Dec 17, 2019 · Past); Optimer Pharmaceuticals Inc (Chief Financial Officer · Jun 25, 2012 – Oct 24, 2013 · Past); Adolor Corp (SVP, Finance & CFO · Sep 9, 2010 – Dec 12, 2011 · Past)
Director · Dec 30, 2016 – Aug 2, 2022 · Past
Theodore R Schroeder
Other companies: Phathom Pharmaceuticals, Inc. (Director · Since at least Apr 16, 2025); Cidara Therapeutics Inc (Director · Since at least Apr 14, 2015); Collegium Pharmaceutical, Inc. (Director · Jan 22, 2016 – May 20, 2020 · Past); Otonomy Inc (Director · Aug 28, 2015 – Jun 21, 2022 · Past); Hyperion Therapeutics Inc (Director · Aug 11, 2014 – May 7, 2015 · Past); Trius Therapeutics Inc (Director · Aug 2, 2010 – Sep 11, 2013 · Past); Cadence Pharmaceuticals Inc (President, CEO, Director · Oct 24, 2006 – Mar 19, 2014 · Past)
Director · Jul 24, 2018 – Jan 29, 2023 · Past
Gary Sender
Other companies: Apnimed, Inc. (Director · Since at least Jul 30, 2026); iBio, Inc. (Director · Since at least Oct 14, 2020); Harmony Biosciences Holdings, Inc. (Director · Since at least Aug 18, 2020); Schrodinger, Inc. (Board Member · Since at least Feb 5, 2020); Synergy Pharmaceuticals Inc (EVP and CFO · Nov 16, 2015 – Nov 16, 2015 · Past)
Chief Financial Officer · Dec 30, 2016 – Feb 28, 2021 · Past
Axel Bolte
Other companies: Inozyme Pharma Inc (Director · Since at least Jul 23, 2020); Allena Pharmaceuticals Inc (Director · Nov 1, 2017 – Jun 8, 2018 · Past); IVERIC bio Inc (Director · Sep 24, 2013 – Jul 11, 2023 · Past); PTC Therapeutics, Inc. (Director · Jun 19, 2013 – Jun 25, 2013 · Past)
Director · Dec 30, 2016 – Dec 30, 2016 · Past
Daniel D Burgess
Other companies: Cidara Therapeutics Inc (Director · Since at least Apr 14, 2015); Arbutus Biopharma Corporation (Director · Mar 23, 2017 – May 23, 2024 · Past); Santarus Inc (Director · Jun 7, 2006 – Jan 2, 2014 · Past)
Director · Dec 30, 2016 – Aug 2, 2022 · Past
Carrie L. Bourdow
Other companies: Trevena, Inc. (President and Chief Executive Officer · Since at least May 4, 2015); Sesen Bio Inc (Director · Feb 24, 2020 – Jun 22, 2022 · Past)
Director · Jun 23, 2017 – Aug 1, 2022 · Past
J Christopher Naftzger
Other companies: Arbutus Biopharma Corporation (General Counsel and CCO · Jul 10, 2023 – Feb 14, 2025 · Past); Unilife Corp (See Remarks · Jul 6, 2010 – May 28, 2013 · Past)
General Counsel and Corp Sec · Jan 28, 2021 – Aug 11, 2022 · Past
All 19 people
PersonSeat
John Peter Wolf III
Other companies: Aceragen Inc. (General Counsel · Dec 10, 2014 – Dec 10, 2014 · Past); Viropharma Inc (VP, General Counsel · Jun 10, 2013 – Jan 24, 2014 · Past)
General Counsel and Corp. Sec. · Dec 30, 2016 – Dec 30, 2016 · Past
Daniel Dolan
Other companies: Radius Health, Inc. (VP of Finance · Sep 24, 2020 – Nov 9, 2020 · Past)
Chief Financial Officer · Mar 12, 2021 – Aug 11, 2022 · Past
Colin MD BroomDirector · Aug 2, 2022 – Aug 2, 2022 · Past
David MaggioChief Financial Officer · Jun 30, 2023 – Jun 30, 2023 · Past
Elyse G SeltzerChief Medical Officer · Dec 30, 2016 – Jun 23, 2017 · Past
Francesco Maria LavinoChief Commercial Officer · Jul 10, 2017 – Sep 30, 2020 · Past
Jennifer SchranzChief Medical Officer · Sep 30, 2020 – Feb 28, 2021 · Past
Lisa DaltonDirector · Jun 2, 2021 – Jul 31, 2022 · Past
Steven P GeloneDirector · Dec 30, 2016 – Jan 29, 2023 · Past

Open People

Log in to ask 6ix AI your own questions about Nabriva Therapeutics AG.